Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.3450
-0.0100 (-2.82%)
Aug 1, 2025, 4:10 PM AEST
Theseus Pharmaceuticals Market Cap
ASX:PAR has a market cap or net worth of 137.11 million as of August 1, 2025. Its market cap has increased by 26.24% in one year.
Market Cap
137.11M
Enterprise Value
112.52M
Revenue
16.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 137.11M, an increase of 323.13%. That is a compound annual growth rate of 15.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 137.11M | -6.11% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | 584.38M | 1.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.17B |
| Pro Medicus | 33.40B |
| Cochlear | 20.83B |
| Sonic Healthcare | 13.65B |
| Ramsay Health Care | 8.91B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |